Guardant Health(GH) - 2022 Q1 - Quarterly Report
Guardant Health(GH)2022-05-04 16:00☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _____________________ FORM 10-Q _____________________ (Mark One) Securities registered pursuant to Section 12(b) of the Act: | Title of each class | Trading Symbol(s) | Name of e ...